Abstract |
Paraoxonase-1 (PON-1) is a high-density lipoprotein (HDL)-associated enzyme that hydrolyzes oxidized phospholipids, thereby preventing the oxidative modification of low-density lipoproteins ( LDL). A high-fat diet reduces PON-1 activity, enhancing LDL oxidation. Thus, PON-1 is a candidate for anti-atherogenic gene therapy. In the present study, we investigated the effect of local PON-1 overexpression on the development of atherosclerotic lesions using the Sendai virus-mediated transgenic technique. One-month-old rabbits (n=11) were fed a high-fat diet for 8 weeks and then subjected to balloon injury of the common iliac artery and simultaneous infection with a Sendai virus vector containing the PON-1 gene (n=7) or enhanced green fluorescence protein (EGFP) gene as a control (n=4). The arteries were examined 7-10 days after the operation. Local overexpression of PON-1 almost completely eliminated the immunohistochemical signals of the lectin-like oxidized LDL receptor-1 (LOX-1), thereby inhibiting macrophage accumulation, intimal thickening (by 63% compared with control), or atherosclerotic plaque formation in the vascular lumen (by 87.5%). Decreased levels of oxidative stress in the PON-1-treated arteries were confirmed by 4-hydroxy-2-nonenal (HNE) staining. Local overexpression of PON-1 in the arteries attenuated oxidative stress, thereby inhibiting the atherosclerotic process. Delivery of the PON-1 gene may be a possible therapeutic strategy for preventing atherosclerosis.
|
Authors | Miwa Miyoshi, Yukiko Nakano, Takemasa Sakaguchi, Hiroshi Ogi, Noboru Oda, Kazuyoshi Suenari, Katsuhiro Kiyotani, Ryoji Ozono, Tetsuya Oshima, Tetsuya Yoshida, Kazuaki Chayama |
Journal | Hypertension research : official journal of the Japanese Society of Hypertension
(Hypertens Res)
Vol. 30
Issue 1
Pg. 85-91
(Jan 2007)
ISSN: 0916-9636 [Print] England |
PMID | 17460375
(Publication Type: Journal Article)
|
Chemical References |
- Dietary Fats
- Lipids
- Lipoproteins
- Matrix Metalloproteinase Inhibitors
- Scavenger Receptors, Class E
- Aryldialkylphosphatase
|
Topics |
- Animals
- Aryldialkylphosphatase
(genetics, metabolism, pharmacology)
- Atherosclerosis
(prevention & control)
- Catheterization
- Cell Line
- Dietary Fats
(administration & dosage)
- Gene Transfer Techniques
- Genetic Vectors
- Hyperplasia
- Iliac Artery
(drug effects, metabolism, pathology)
- Lipids
(blood)
- Lipoproteins
(blood)
- Male
- Matrix Metalloproteinase Inhibitors
- Oxidative Stress
(drug effects)
- Rabbits
- Rats
- Scavenger Receptors, Class E
(antagonists & inhibitors)
- Sendai virus
(genetics)
- Tunica Intima
(drug effects, pathology)
|